Literature DB >> 24936317

Monte Carlo characterizations mapping of the (γ,n) and (n,γ) photonuclear reactions in the high energy X-ray radiation therapy.

Hosein Ghiasi1.   

Abstract

AIM: The aim of this work was to map the characteristics of (n,γ) and (γ,n) reactions in a high energy photon radiation therapy.
BACKGROUND: Photoneutrons produced in the high energy X-Ray radiation therapy may damage patients and staff. It is due to high RBE of the produced neutrons according to their energy and isotropic emission. Characterization of the photoneutrons can help us in appropriate shielding.
MATERIALS AND METHODS: This study focused on the photoneutron and capture gamma ray phenomena. Characteristics such as dose value, fluence and spectra of both the neutrons and the by produced prompt gamma ray were described. RESULTS AND DISCUSSION: Neutron and prompt gamma spectra in different points showed the neutrons to be thermalized when increasing the distance from the linac. Energy of the neutrons changed from about 0.6 MeV at the isocentre to around 10(-08) MeV at the outer door position. Although the neutrons were found as fast neutrons, their spectra showed they were thermal neutrons at the outer door position. Additionally, it was seen that the energy of the gamma rays is higher than the scattered X-ray energy. The energy of gamma rays was seen to be up to 10 MeV while the linac photons had energy lower than 1 MeV. Neutron source strength obtained in this work was in good agreement with the published data, which may be a confirmation of our simulation accuracy.
CONCLUSION: The study showed that the Monte Carlo simulation can be applied in the radiotherapy and industrial radiation works as a useful and precise estimator. We also concluded that the dose from the prompt gamma ray at the outer door location is higher than the scattered radiation from the linac and should be considered in the shielding.

Entities:  

Keywords:  Capture gamma ray; Monte Carlo; Photoneutron; Shielding

Year:  2013        PMID: 24936317      PMCID: PMC4054887          DOI: 10.1016/j.rpor.2013.07.003

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  23 in total

1.  Depth dose-equivalent and effective energies of photoneutrons generated by 6-18 MV X-ray beams for radiotherapy.

Authors:  F d'Errico; M Luszik-Bhadra; R Nath; B R Siebert; U Wolf
Journal:  Health Phys       Date:  2001-01       Impact factor: 1.316

2.  Photoneutron yields from tungsten in the energy range of the giant dipole resonance.

Authors:  I Akkurt; J O Adler; J R M Annand; F Fasolo; K Hansen; L Isaksson; M Karlsson; P Lilja; M Lundin; B Nilsson; C Ongaro; A Reiter; G Rosner; A Sandell; B Schröder; A Zanini
Journal:  Phys Med Biol       Date:  2003-10-21       Impact factor: 3.609

3.  Monte Carlo simulation of the photoneutron field in linac radiotherapy treatments with different collimation systems.

Authors:  A Zanini; E Durisi; F Fasolo; C Ongaro; L Visca; U Nastasi; K W Burn; G Scielzo; J O Adler; J R M Annand; G Rosner
Journal:  Phys Med Biol       Date:  2004-02-21       Impact factor: 3.609

4.  Neutron measurements in a Varian 2,100C LINAC facility using a Bonner sphere system based on passive gold activation detectors.

Authors:  F Fernández; C Domingo; K Amgarou; J Castelo; T Bouassoule; M J Garcia; E Luguera
Journal:  Radiat Prot Dosimetry       Date:  2007-05-24       Impact factor: 0.972

5.  Photoneutron production of a Siemens Primus linear accelerator studied by Monte Carlo methods and a paired magnesium and boron coated magnesium ionization chamber system.

Authors:  J Becker; E Brunckhorst; R Schmidt
Journal:  Phys Med Biol       Date:  2007-10-11       Impact factor: 3.609

6.  Measurement of the neutron leakage from a dedicated intraoperative radiation therapy electron linear accelerator and a conventional linear accelerator for 9, 12, 15(16), and 18(20) MeV electron energies.

Authors:  Adnan K Jaradat; Peter J Biggs
Journal:  Med Phys       Date:  2008-05       Impact factor: 4.071

7.  Photoneutron production in tissue during high energy bremsstrahlung radiotherapy.

Authors:  P D Allen; M A Chaudhri
Journal:  Phys Med Biol       Date:  1988-09       Impact factor: 3.609

8.  Calculation of neutron yields released by electrons incident on selected materials.

Authors:  W P Swanson
Journal:  Health Phys       Date:  1978-08       Impact factor: 1.316

9.  Heavy metal shielding for neutron sources.

Authors:  R C McCall; H E Hootman
Journal:  Health Phys       Date:  1978-10       Impact factor: 1.316

10.  Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators.

Authors:  David S Followill; Marilyn S Stovall; Stephen F Kry; Geoffrey S Ibbott
Journal:  J Appl Clin Med Phys       Date:  2003       Impact factor: 2.102

View more
  5 in total

1.  Safe bunker designing for the 18 MV Varian 2100 Clinac: a comparison between Monte Carlo simulation based upon data and new protocol recommendations.

Authors:  Manije Beigi; Fatemeh Afarande; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-17

2.  MC safe bunker designing for an 18 MV linac with nanoparticles included primary barriers and effect of the nanoparticles on the shielding aspects.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-06

3.  Monte Carlo study on the secondary cancer risk estimations for patients undergoing prostate radiotherapy: A humanoid phantom study.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-10

4.  Application of the phase-space distribution approach of Monte Carlo for radiation contamination dose estimation from the (n,γ), (γ,n) nuclear reactions and linac leakage photons in the megavoltage radiotherapy facility.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-24

5.  Monte Carlo calculation of photo-neutron dose produced by circular cones at 18 MV photon beams.

Authors:  Elham Hosseinzadeh; Nooshin Banaee; Hassan Ali Nedaie
Journal:  Rep Pract Oncol Radiother       Date:  2018-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.